Last winter, a mutated flu variant called H3N2 subclade K caused an intense and disruptive flu season in the U.S. — doctor visits for flu-like symptoms hit a nearly 30-year high. Will this year bring ...
Programming languages that power the internet are often a lot older than you think. While a ton of new frameworks or variations on popular languages are released regularly, major sites and most of the ...
Share on Pinterest Moderna’s new mRNA flu vaccine has been approved by the FDA for adults ages 50 years and older. FatCamera, E+/Getty Images The Food and Drug Administration (FDA) has approved ...
Flu season typically begins in the fall and peaks during the winter months from December through February. The CDC recommends most people get their flu shot in September or October for optimal ...
On August 5, 2026 the U.S. Food and Drug Administration (FDA) approved the first-ever messenger RNA (mRNA) flu vaccine for adults 50 and older. Manufactured by Moderna, the vaccine is expected to be ...
mRNA flu shots have officially arrived. On August 5, the U.S. Food and Drug Administration approved the first influenza vaccine that uses the same technology underpinning COVID-19 shots. The flu ...
On Wednesday, the U.S. Food and Drug Administration approved the country’s first mRNA flu shot, mFlusiva, from the drugmaker Moderna. The shot was given a traditional approval for adults ages 50 to 64 ...
The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses mRNA technology, the drugmaker announced Wednesday. Called mFLUSIVA, it is approved for adults ages ...
The FDA has approved Moderna’s mFLUSIVA (mRNA-1010), the first mRNA-based influenza vaccine in the U.S., for the prevention of seasonal influenza in adults ages 50 and older. The decision follows a ...
In a first, the U.S. has approved an influenza vaccine that relies on mRNA technology—the same technology that underpinned the wildly successful Pfizer-BioNTech and Moderna COVID vaccines. The ...
The Food and Drug Administration (FDA) late Wednesday approved the nation’s first mRNA flu vaccine, manufactured by drugmaker Moderna. The agency approved the shot for two separate age groups: people ...
Siladitya Ray is a New Delhi-based Forbes news team reporter. In a statement, vaccine maker Moderna said its “mFLUSIVA” vaccine against seasonal influenza has been approved for use by all adults aged ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results